Literature DB >> 20042889

Employment and work impact of chronic migraine and episodic migraine.

Walter F Stewart1, G Craig Wood, Aubrey Manack, Sepideh F Varon, Dawn C Buse, Richard B Lipton.   

Abstract

OBJECTIVE: To determine work impact of chronic migraine (CM) versus episodic migraine (EM).
METHODS: Data were from the 2005 American Migraine Prevalence and Prevention study, a longitudinal population survey of more than 11,000 migraineurs. Lost productive time (LPT) was measured as missed work hours plus reduced productivity hour equivalents.
RESULTS: Those with CM were 19% less likely to be working for pay compared with migraineurs with <or=3 headache-days/month. On average, those with CM lost 4.6 hours/wk from headache compared with 1.1 hours for those with <or=3 headache-days/month. Those with 10 to 14 headache-days/month or with CM accounted for 9.1% of employed migraineurs, 20.8% of work-related LPT, and 35% of the overall lost work time when considering medical leave and unemployment.
CONCLUSIONS: The work impact of CM and high frequency EM will be underestimated if employment status is not measured.

Entities:  

Mesh:

Year:  2010        PMID: 20042889     DOI: 10.1097/JOM.0b013e3181c1dc56

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  49 in total

1.  Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS).

Authors:  L M Bloudek; M Stokes; D C Buse; T K Wilcox; R B Lipton; P J Goadsby; S F Varon; A M Blumenfeld; Z Katsarava; J Pascual; M Lanteri-Minet; P Cortelli; P Martelletti
Journal:  J Headache Pain       Date:  2012-05-29       Impact factor: 7.277

Review 2.  A Critical Evaluation on MOH Current Treatments.

Authors:  Andrea Negro; Martina Curto; Luana Lionetto; Simona Guerzoni; Luigi Alberto Pini; Paolo Martelletti
Journal:  Curr Treat Options Neurol       Date:  2017-08-15       Impact factor: 3.598

3.  Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group†.

Authors:  Eric Schiffman; Richard Ohrbach; Edmond Truelove; John Look; Gary Anderson; Jean-Paul Goulet; Thomas List; Peter Svensson; Yoly Gonzalez; Frank Lobbezoo; Ambra Michelotti; Sharon L Brooks; Werner Ceusters; Mark Drangsholt; Dominik Ettlin; Charly Gaul; Louis J Goldberg; Jennifer A Haythornthwaite; Lars Hollender; Rigmor Jensen; Mike T John; Antoon De Laat; Reny de Leeuw; William Maixner; Marylee van der Meulen; Greg M Murray; Donald R Nixdorf; Sandro Palla; Arne Petersson; Paul Pionchon; Barry Smith; Corine M Visscher; Joanna Zakrzewska; Samuel F Dworkin
Journal:  J Oral Facial Pain Headache       Date:  2014

Review 4.  Opioid Treatment of Migraine: Risk Factors and Behavioral Issues.

Authors:  Melissa T Stone; Valerie Weed; Ronald J Kulich
Journal:  Curr Pain Headache Rep       Date:  2016-09

Review 5.  Economic burden and costs of chronic migraine.

Authors:  Michel Lanteri-Minet
Journal:  Curr Pain Headache Rep       Date:  2014-01

Review 6.  Difficulties in work-related activities among migraineurs are scarcely collected: results from a literature review.

Authors:  A Raggi; V Covelli; M Leonardi; L Grazzi; M Curone; D D'Amico
Journal:  Neurol Sci       Date:  2014-05       Impact factor: 3.307

Review 7.  Outcome of Chronic Daily Headache or Chronic Migraine.

Authors:  Soo-Jin Cho; Tae-Jin Song; Min Kyung Chu
Journal:  Curr Pain Headache Rep       Date:  2016-01

Review 8.  Dihydroergotamine: a review of formulation approaches for the acute treatment of migraine.

Authors:  Stephen D Silberstein; Shashidhar H Kori
Journal:  CNS Drugs       Date:  2013-05       Impact factor: 5.749

9.  [Consensus paper of the German Migraine and Headache Society on the structure of headache care facilities in Germany].

Authors:  M Marziniak; V Malzacher; S Förderreuther; T Jürgens; P Kropp; A May; A Straube
Journal:  Schmerz       Date:  2014-04       Impact factor: 1.107

Review 10.  Invasive and Non-invasive Electrical Pericranial Nerve Stimulation for the Treatment of Chronic Primary Headaches.

Authors:  Kevin D'Ostilio; Delphine Magis
Journal:  Curr Pain Headache Rep       Date:  2016-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.